Loading…

DNA methylation markers for oral cancer detection in non- and minimally invasive samples: a systematic review

More than 50% of oral cancer (OC) patients are diagnosed with advanced-stage disease associated with poor prognosis and quality of life, supporting an urgent need to improve early OC detection. The identification of effective molecular markers by minimally invasive approaches has emerged as a promis...

Full description

Saved in:
Bibliographic Details
Published in:Clinical epigenetics 2024-08, Vol.16 (1), p.105-12, Article 105
Main Authors: Rapado-González, Óscar, Salta, Sofia, López-López, Rafael, Henrique, Rui, Suárez-Cunqueiro, María Mercedes, Jerónimo, Carmen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c417t-e46c68116ecbe3bf2164a0ff03862180245b9ddb094e8f026f9b3d54206124c03
container_end_page 12
container_issue 1
container_start_page 105
container_title Clinical epigenetics
container_volume 16
creator Rapado-González, Óscar
Salta, Sofia
López-López, Rafael
Henrique, Rui
Suárez-Cunqueiro, María Mercedes
Jerónimo, Carmen
description More than 50% of oral cancer (OC) patients are diagnosed with advanced-stage disease associated with poor prognosis and quality of life, supporting an urgent need to improve early OC detection. The identification of effective molecular markers by minimally invasive approaches has emerged as a promising strategy for OC screening. This systematic review summarizes and evaluates the performance of the DNA methylation markers identified in non- or minimally invasive samples for OC detection. PubMed's MEDLINE, Scopus, Embase, and Cochrane Library databases were systematically searched for studies that evaluated DNA methylation markers in non-invasive and/or minimally invasive samples (oral rinse/saliva, oral brush, and blood) from OC patients. Two investigators independently extracted data on study population characteristics, candidate methylation markers, testing samples, DNA methylation assay, and performance diagnostic outcomes. Methodological study quality was assessed with the Quality Assessment for Studies of Diagnostic Accuracy-2 tool. Thirty-one studies met the inclusion criteria for this systematic review. DNA methylation markers were evaluated in oral rinse/saliva (n = 17), oral brush (n = 9), and blood (n = 7) samples. Methylation-specific PCR (MSP) and quantitative-MSP were the most common DNA methylation assays. Regarding diagnostic performance values for salivary, oral brush, and blood DNA methylation markers, sensitivity and specificity ranged between 3.4-100% and 21-100%, 9-100% and 26.8-100%, 22-70% and 45.45-100%, respectively. Different gene methylation panels showed good diagnostic performance for OC detection. This systematic review discloses the promising value of testing DNA methylation markers in non-invasive (saliva or oral rinse) or minimally invasive (oral brush or blood) samples as a novel strategy for OC detection. However, further validation in large, multicenter, and prospective study cohorts must be carried out to confirm the clinical value of specific DNA methylation markers in this setting.
doi_str_mv 10.1186/s13148-024-01716-9
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ccaf5b4c07444139910e11a3cb77b077</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A808248302</galeid><doaj_id>oai_doaj_org_article_ccaf5b4c07444139910e11a3cb77b077</doaj_id><sourcerecordid>A808248302</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-e46c68116ecbe3bf2164a0ff03862180245b9ddb094e8f026f9b3d54206124c03</originalsourceid><addsrcrecordid>eNptUk1vGyEQRVWrJnLzB3qokHrpZVNmwSzbS2WlX5Gi9tKeEcsODukuuLB25H9f1k6jWCoIgWbee3ozDCGvgV0CKPk-AwehKlaLikEDsmqfkfOSUFXDFH_-5H1GLnK-Y2Xxtm2BvSRnvAWuloKdk_HT9xUdcbrdD2byMdDRpN-YMnUx0ZjMQK0JFhPtcUJ7QPhAQwwVNaGnow9-NMOwL9GdyX6HNJtxM2D-QA3N-zzhWHQtTbjzeP-KvHBmyHjxcC_Iry-ff159q25-fL2-Wt1UVkAzVSiklQpAou2Qd64GKQxzjnEla1Cl5mXX9n3HWoHKsVq6tuP9UtRMQi0s4wtyfdTto7nTm1Q8pr2OxutDIKa1NqnYGlBba9yyK6RGCAF8bhACGG67pulY0xStj0etzbYbsbcYptKWE9HTTPC3eh13GoDXXJazIO8eFFL8s8U86dFni8NgAsZt1py1dfksAW2Bvj1C16Z488HFImlnuF4ppmqhOJsFL_-DKrvH0dsY0PkSPyHUR4JNMeeE7tE-MD2Pkz6Oky6t1Ydx0rOXN08Lf6T8Gx7-F-azxJ0</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3092868419</pqid></control><display><type>article</type><title>DNA methylation markers for oral cancer detection in non- and minimally invasive samples: a systematic review</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Rapado-González, Óscar ; Salta, Sofia ; López-López, Rafael ; Henrique, Rui ; Suárez-Cunqueiro, María Mercedes ; Jerónimo, Carmen</creator><creatorcontrib>Rapado-González, Óscar ; Salta, Sofia ; López-López, Rafael ; Henrique, Rui ; Suárez-Cunqueiro, María Mercedes ; Jerónimo, Carmen</creatorcontrib><description>More than 50% of oral cancer (OC) patients are diagnosed with advanced-stage disease associated with poor prognosis and quality of life, supporting an urgent need to improve early OC detection. The identification of effective molecular markers by minimally invasive approaches has emerged as a promising strategy for OC screening. This systematic review summarizes and evaluates the performance of the DNA methylation markers identified in non- or minimally invasive samples for OC detection. PubMed's MEDLINE, Scopus, Embase, and Cochrane Library databases were systematically searched for studies that evaluated DNA methylation markers in non-invasive and/or minimally invasive samples (oral rinse/saliva, oral brush, and blood) from OC patients. Two investigators independently extracted data on study population characteristics, candidate methylation markers, testing samples, DNA methylation assay, and performance diagnostic outcomes. Methodological study quality was assessed with the Quality Assessment for Studies of Diagnostic Accuracy-2 tool. Thirty-one studies met the inclusion criteria for this systematic review. DNA methylation markers were evaluated in oral rinse/saliva (n = 17), oral brush (n = 9), and blood (n = 7) samples. Methylation-specific PCR (MSP) and quantitative-MSP were the most common DNA methylation assays. Regarding diagnostic performance values for salivary, oral brush, and blood DNA methylation markers, sensitivity and specificity ranged between 3.4-100% and 21-100%, 9-100% and 26.8-100%, 22-70% and 45.45-100%, respectively. Different gene methylation panels showed good diagnostic performance for OC detection. This systematic review discloses the promising value of testing DNA methylation markers in non-invasive (saliva or oral rinse) or minimally invasive (oral brush or blood) samples as a novel strategy for OC detection. However, further validation in large, multicenter, and prospective study cohorts must be carried out to confirm the clinical value of specific DNA methylation markers in this setting.</description><identifier>ISSN: 1868-7083</identifier><identifier>ISSN: 1868-7075</identifier><identifier>EISSN: 1868-7083</identifier><identifier>DOI: 10.1186/s13148-024-01716-9</identifier><identifier>PMID: 39138540</identifier><language>eng</language><publisher>Germany: BioMed Central Ltd</publisher><subject>Biomarkers, Tumor - blood ; Biomarkers, Tumor - genetics ; Cancer ; Diagnosis ; DNA ; DNA methylation ; DNA Methylation - genetics ; Early Detection of Cancer - methods ; Epigenetic inheritance ; Epigenetics ; Genes ; Genetic aspects ; Health aspects ; Humans ; Liquid biopsies ; Methylation ; Mouth cancer ; Mouth Neoplasms - diagnosis ; Mouth Neoplasms - genetics ; Oral cancer ; Oral medication ; Review ; Saliva - chemistry ; Screening ; Sensitivity and Specificity</subject><ispartof>Clinical epigenetics, 2024-08, Vol.16 (1), p.105-12, Article 105</ispartof><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c417t-e46c68116ecbe3bf2164a0ff03862180245b9ddb094e8f026f9b3d54206124c03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11323632/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11323632/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,36990,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39138540$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rapado-González, Óscar</creatorcontrib><creatorcontrib>Salta, Sofia</creatorcontrib><creatorcontrib>López-López, Rafael</creatorcontrib><creatorcontrib>Henrique, Rui</creatorcontrib><creatorcontrib>Suárez-Cunqueiro, María Mercedes</creatorcontrib><creatorcontrib>Jerónimo, Carmen</creatorcontrib><title>DNA methylation markers for oral cancer detection in non- and minimally invasive samples: a systematic review</title><title>Clinical epigenetics</title><addtitle>Clin Epigenetics</addtitle><description>More than 50% of oral cancer (OC) patients are diagnosed with advanced-stage disease associated with poor prognosis and quality of life, supporting an urgent need to improve early OC detection. The identification of effective molecular markers by minimally invasive approaches has emerged as a promising strategy for OC screening. This systematic review summarizes and evaluates the performance of the DNA methylation markers identified in non- or minimally invasive samples for OC detection. PubMed's MEDLINE, Scopus, Embase, and Cochrane Library databases were systematically searched for studies that evaluated DNA methylation markers in non-invasive and/or minimally invasive samples (oral rinse/saliva, oral brush, and blood) from OC patients. Two investigators independently extracted data on study population characteristics, candidate methylation markers, testing samples, DNA methylation assay, and performance diagnostic outcomes. Methodological study quality was assessed with the Quality Assessment for Studies of Diagnostic Accuracy-2 tool. Thirty-one studies met the inclusion criteria for this systematic review. DNA methylation markers were evaluated in oral rinse/saliva (n = 17), oral brush (n = 9), and blood (n = 7) samples. Methylation-specific PCR (MSP) and quantitative-MSP were the most common DNA methylation assays. Regarding diagnostic performance values for salivary, oral brush, and blood DNA methylation markers, sensitivity and specificity ranged between 3.4-100% and 21-100%, 9-100% and 26.8-100%, 22-70% and 45.45-100%, respectively. Different gene methylation panels showed good diagnostic performance for OC detection. This systematic review discloses the promising value of testing DNA methylation markers in non-invasive (saliva or oral rinse) or minimally invasive (oral brush or blood) samples as a novel strategy for OC detection. However, further validation in large, multicenter, and prospective study cohorts must be carried out to confirm the clinical value of specific DNA methylation markers in this setting.</description><subject>Biomarkers, Tumor - blood</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Cancer</subject><subject>Diagnosis</subject><subject>DNA</subject><subject>DNA methylation</subject><subject>DNA Methylation - genetics</subject><subject>Early Detection of Cancer - methods</subject><subject>Epigenetic inheritance</subject><subject>Epigenetics</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Liquid biopsies</subject><subject>Methylation</subject><subject>Mouth cancer</subject><subject>Mouth Neoplasms - diagnosis</subject><subject>Mouth Neoplasms - genetics</subject><subject>Oral cancer</subject><subject>Oral medication</subject><subject>Review</subject><subject>Saliva - chemistry</subject><subject>Screening</subject><subject>Sensitivity and Specificity</subject><issn>1868-7083</issn><issn>1868-7075</issn><issn>1868-7083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptUk1vGyEQRVWrJnLzB3qokHrpZVNmwSzbS2WlX5Gi9tKeEcsODukuuLB25H9f1k6jWCoIgWbee3ozDCGvgV0CKPk-AwehKlaLikEDsmqfkfOSUFXDFH_-5H1GLnK-Y2Xxtm2BvSRnvAWuloKdk_HT9xUdcbrdD2byMdDRpN-YMnUx0ZjMQK0JFhPtcUJ7QPhAQwwVNaGnow9-NMOwL9GdyX6HNJtxM2D-QA3N-zzhWHQtTbjzeP-KvHBmyHjxcC_Iry-ff159q25-fL2-Wt1UVkAzVSiklQpAou2Qd64GKQxzjnEla1Cl5mXX9n3HWoHKsVq6tuP9UtRMQi0s4wtyfdTto7nTm1Q8pr2OxutDIKa1NqnYGlBba9yyK6RGCAF8bhACGG67pulY0xStj0etzbYbsbcYptKWE9HTTPC3eh13GoDXXJazIO8eFFL8s8U86dFni8NgAsZt1py1dfksAW2Bvj1C16Z488HFImlnuF4ppmqhOJsFL_-DKrvH0dsY0PkSPyHUR4JNMeeE7tE-MD2Pkz6Oky6t1Ydx0rOXN08Lf6T8Gx7-F-azxJ0</recordid><startdate>20240813</startdate><enddate>20240813</enddate><creator>Rapado-González, Óscar</creator><creator>Salta, Sofia</creator><creator>López-López, Rafael</creator><creator>Henrique, Rui</creator><creator>Suárez-Cunqueiro, María Mercedes</creator><creator>Jerónimo, Carmen</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240813</creationdate><title>DNA methylation markers for oral cancer detection in non- and minimally invasive samples: a systematic review</title><author>Rapado-González, Óscar ; Salta, Sofia ; López-López, Rafael ; Henrique, Rui ; Suárez-Cunqueiro, María Mercedes ; Jerónimo, Carmen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-e46c68116ecbe3bf2164a0ff03862180245b9ddb094e8f026f9b3d54206124c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomarkers, Tumor - blood</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Cancer</topic><topic>Diagnosis</topic><topic>DNA</topic><topic>DNA methylation</topic><topic>DNA Methylation - genetics</topic><topic>Early Detection of Cancer - methods</topic><topic>Epigenetic inheritance</topic><topic>Epigenetics</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Liquid biopsies</topic><topic>Methylation</topic><topic>Mouth cancer</topic><topic>Mouth Neoplasms - diagnosis</topic><topic>Mouth Neoplasms - genetics</topic><topic>Oral cancer</topic><topic>Oral medication</topic><topic>Review</topic><topic>Saliva - chemistry</topic><topic>Screening</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rapado-González, Óscar</creatorcontrib><creatorcontrib>Salta, Sofia</creatorcontrib><creatorcontrib>López-López, Rafael</creatorcontrib><creatorcontrib>Henrique, Rui</creatorcontrib><creatorcontrib>Suárez-Cunqueiro, María Mercedes</creatorcontrib><creatorcontrib>Jerónimo, Carmen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ: Directory of Open Access Journals</collection><jtitle>Clinical epigenetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rapado-González, Óscar</au><au>Salta, Sofia</au><au>López-López, Rafael</au><au>Henrique, Rui</au><au>Suárez-Cunqueiro, María Mercedes</au><au>Jerónimo, Carmen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DNA methylation markers for oral cancer detection in non- and minimally invasive samples: a systematic review</atitle><jtitle>Clinical epigenetics</jtitle><addtitle>Clin Epigenetics</addtitle><date>2024-08-13</date><risdate>2024</risdate><volume>16</volume><issue>1</issue><spage>105</spage><epage>12</epage><pages>105-12</pages><artnum>105</artnum><issn>1868-7083</issn><issn>1868-7075</issn><eissn>1868-7083</eissn><abstract>More than 50% of oral cancer (OC) patients are diagnosed with advanced-stage disease associated with poor prognosis and quality of life, supporting an urgent need to improve early OC detection. The identification of effective molecular markers by minimally invasive approaches has emerged as a promising strategy for OC screening. This systematic review summarizes and evaluates the performance of the DNA methylation markers identified in non- or minimally invasive samples for OC detection. PubMed's MEDLINE, Scopus, Embase, and Cochrane Library databases were systematically searched for studies that evaluated DNA methylation markers in non-invasive and/or minimally invasive samples (oral rinse/saliva, oral brush, and blood) from OC patients. Two investigators independently extracted data on study population characteristics, candidate methylation markers, testing samples, DNA methylation assay, and performance diagnostic outcomes. Methodological study quality was assessed with the Quality Assessment for Studies of Diagnostic Accuracy-2 tool. Thirty-one studies met the inclusion criteria for this systematic review. DNA methylation markers were evaluated in oral rinse/saliva (n = 17), oral brush (n = 9), and blood (n = 7) samples. Methylation-specific PCR (MSP) and quantitative-MSP were the most common DNA methylation assays. Regarding diagnostic performance values for salivary, oral brush, and blood DNA methylation markers, sensitivity and specificity ranged between 3.4-100% and 21-100%, 9-100% and 26.8-100%, 22-70% and 45.45-100%, respectively. Different gene methylation panels showed good diagnostic performance for OC detection. This systematic review discloses the promising value of testing DNA methylation markers in non-invasive (saliva or oral rinse) or minimally invasive (oral brush or blood) samples as a novel strategy for OC detection. However, further validation in large, multicenter, and prospective study cohorts must be carried out to confirm the clinical value of specific DNA methylation markers in this setting.</abstract><cop>Germany</cop><pub>BioMed Central Ltd</pub><pmid>39138540</pmid><doi>10.1186/s13148-024-01716-9</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1868-7083
ispartof Clinical epigenetics, 2024-08, Vol.16 (1), p.105-12, Article 105
issn 1868-7083
1868-7075
1868-7083
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ccaf5b4c07444139910e11a3cb77b077
source Publicly Available Content Database; PubMed Central
subjects Biomarkers, Tumor - blood
Biomarkers, Tumor - genetics
Cancer
Diagnosis
DNA
DNA methylation
DNA Methylation - genetics
Early Detection of Cancer - methods
Epigenetic inheritance
Epigenetics
Genes
Genetic aspects
Health aspects
Humans
Liquid biopsies
Methylation
Mouth cancer
Mouth Neoplasms - diagnosis
Mouth Neoplasms - genetics
Oral cancer
Oral medication
Review
Saliva - chemistry
Screening
Sensitivity and Specificity
title DNA methylation markers for oral cancer detection in non- and minimally invasive samples: a systematic review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A08%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DNA%20methylation%20markers%20for%20oral%20cancer%20detection%20in%20non-%20and%20minimally%20invasive%20samples:%20a%20systematic%20review&rft.jtitle=Clinical%20epigenetics&rft.au=Rapado-Gonz%C3%A1lez,%20%C3%93scar&rft.date=2024-08-13&rft.volume=16&rft.issue=1&rft.spage=105&rft.epage=12&rft.pages=105-12&rft.artnum=105&rft.issn=1868-7083&rft.eissn=1868-7083&rft_id=info:doi/10.1186/s13148-024-01716-9&rft_dat=%3Cgale_doaj_%3EA808248302%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c417t-e46c68116ecbe3bf2164a0ff03862180245b9ddb094e8f026f9b3d54206124c03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3092868419&rft_id=info:pmid/39138540&rft_galeid=A808248302&rfr_iscdi=true